Table 1 Clinicopathological and survival information for the PDAC cases

From: Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma

Cohort

VLST

STS

UCLA TMA cohort

No. of cases

5

5

145

Age, years

 <60

2

1

49

 ≥60

3

4

96

Gender

 M

3

2

75

 F

2

3

70

Survival time

 Mean

>10 years

10 months

34.7 months

 Range

>10 years

6–14 months

0.49–100 months

Tumor size

 <3 cm

2

1

87

 ≥3 cm

3

4

58

Tumor grade

 Low grade (G1-2)

0

0

83

 High grade (G3-4)

5

5

62

AJCC stage

 1

1

 

40

 2

4

 

105

 Unknown

0

5

0

Lymph nodes

 Negative

2

3

69

 Positive

3

2

76